Sabal Trust CO Abbott Laboratories Transaction History

Sabal Trust CO

$1.83 Billion
Q3 2024

A detailed history of Sabal Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Sabal Trust CO holds 124,035 shares of ABT stock, worth $14.6 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

124,035

Previous 123,774 0.21%

Holding current value

$14.6 Million

Previous $12.9 Million 9.95%

% of portfolio

0.77%

Previous 0.77%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $26,118 - $30,831	261 Added 0.21%	124,035 $14.1 Million
Q2 2024 Jul 30, 2024	SELL	$100.73 - $112.44 $386,299 - $431,207	-3,835 Reduced 3.01%	123,774 $12.9 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $59,688 - $65,923	-545 Reduced 0.43%	127,609 $14.5 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $267,503 - $327,446	2,966 Added 2.37%	128,154 $14.1 Million
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $11,654 - $13,983	122 Added 0.1%	125,188 $12.1 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $11.9 Million - $13.3 Million	118,230 Added 1729.52%	125,066 $13.6 Million
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $17,434 - $20,521	-180 Reduced 2.57%	6,836 $692,000
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $111,220 - $130,478	-1,170 Reduced 14.29%	7,016 $770,000
Q3 2022 Oct 18, 2022	BUY	$96.76 - $112.03 $373,009 - $431,875	3,855 Added 89.01%	8,186 $792,000
Q2 2022 Jul 18, 2022	BUY	$102.07 - $123.37 $442,065 - $534,315	4,331 New	4,331 $470,000
Q1 2022 Apr 14, 2022	SELL	$114.02 - $139.04 $704,643 - $859,267	-6,180 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $5,776 - $7,073	-50 Reduced 0.8%	6,180 $870,000
Q2 2021 Jul 16, 2021	SELL	$105.79 - $124.53 $71,090 - $83,684	-672 Reduced 9.74%	6,230 $722,000
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $26,121 - $30,775	-240 Reduced 3.36%	6,902 $827,000
Q4 2020 Jan 20, 2021	BUY	$105.0 - $114.42 $525 - $572	5 Added 0.07%	7,142 $782,000
Q3 2020 Oct 14, 2020	SELL	$91.64 - $111.29 $378,473 - $459,627	-4,130 Reduced 36.66%	7,137 $777,000
Q2 2020 Jul 13, 2020	SELL	$76.57 - $98.0 $123,966 - $158,662	-1,619 Reduced 12.56%	11,267 $1.03 Million
Q1 2020 Apr 14, 2020	BUY	$62.82 - $91.86 $60,998 - $89,196	971 Added 8.15%	12,886 $1.02 Million
Q4 2019 Jan 14, 2020	SELL	$78.51 - $87.4 $58,961 - $65,637	-751 Reduced 5.93%	11,915 $1.04 Million
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $325,477 - $352,918	3,977 Added 45.77%	12,666 $1.06 Million
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $26,156 - $31,623	395 Added 4.76%	8,689 $695,000
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $6,556 - $7,427	-100 Reduced 1.19%	8,294 $599,000
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $4,256 - $5,135	70 Added 0.84%	8,394 $615,000
Q2 2018 Jul 16, 2018	SELL	$57.57 - $63.54 $437,532 - $482,904	-7,600 Reduced 47.73%	8,324 $508,000
Q1 2018 Apr 16, 2018	BUY	$56.27 - $63.62 $209,324 - $236,666	3,720 Added 30.48%	15,924 $954,000
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $39,401 - $42,182	734 Added 6.4%	12,204 $697,000
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $551,248 - $615,250	11,470	11,470 $612,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.

Account